This interaction, coupled with increased DR5 expression on HSCs, inhibits collagen formation and extracellular matrix (ECM) deposition, mitigating liver fibrosis (Tao et al., 2021). The gene discussed is TNFRSF10B; the disease is Hepatic fibrosis.